Janssen Biotech

Janssen Biotech, part of Johnson & Johnson Innovative Medicine, develops breakthrough treatments in oncology, immunology, neuroscience, and cardiopulmonary diseases. They focus on patient-centered innovation and rigorous science to transform healthcare globally.